Short answer
PROCEPT BioRobotics Corp (PRCT) filed its Q2 2026 10-Q quarterly report on Aug 5, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $94M (up 19.3% year over year) with net income of −$27M.
Q2 2026 key financials · XBRL
- Revenue
- $94M
- +19.3% YoY · +13.7% QoQ
- Net income
- −$27M
- −37.2% YoY · +15.1% QoQ
- Operating margin
- -29.0%
- Gross margin
- 66.0%
- EPS (diluted)
- −$0.47
- −34.3% YoY · +16.1% QoQ
Source: XBRL data from the PROCEPT BioRobotics Corp (PRCT) Q2 2026 10-Q on SEC EDGAR. USD.
PROCEPT BioRobotics Corp Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $94.5M, up 19% YoY from $79.2M
- Gross margin 66% vs 65% YoY, including a $2.9M one-time tariff refund
- Best line: system sales and leases $32.5M, up 30% YoY
- Net cash used in operations $57.4M vs $32.0M; cash and equivalents $227.9M
- Outlook: cash and anticipated revenue expected to fund operations through at least next twelve months
Risk Factors
- No material risk-factor changes during six months ended June 30, 2026
- Carried-forward healthcare-industry and company-specific risks from December 31, 2025 10-K
- Unknown or currently immaterial risks could materially affect business, cash flows, or results
- Historical financial performance not reliable for forecasting future results or trends
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other PROCEPT BioRobotics Corp quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.